Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?

Dominique Larrey (1) , Lucy Meunier (1) , José Ursic-Bedoya (1)

1 Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB)

Liver biopsy is still useful in selected clinical situations in which it is the only tool to obtain information necessary for the diagnosis, the prognosis, and the decision for treatment. Main examples are viral hepatitis with confounding co-morbidities, non alcoholic fatty liver disease, and autoimmune liver diseases.

Mots clés: Humans; Liver Cirrhosis; Risk Factors; Prognosis; Biopsy; chronic liver disease; cirrhosis; co-morbidities; Comorbidity; fibrosis; Hepatitis; Autoimmune; Chronic; Liver; liver biopsy; Non-alcoholic Fatty Liver Disease; Predictive Value of Tests

Domaines: Sciences du Vivant [q-bio]

Dominique Larrey, Lucy Meunier, José Ursic-Bedoya. Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?. Annals of hepatology : official journal of the Mexican Association of Hepatology, 2017, 16 (4), pp.487--489. ⟨10.5604/01.3001.0010.0272⟩. ⟨hal-01760709⟩